Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey's Max Jackson promoted

Sudler & Hennessey has announced that Max Jackson has been promoted to CEO of both its EMEA and APAC regions

Sudler & Hennessey has announced that Max Jackson has been promoted to CEO of both its Europe/Middle East/Africa (EMEA) and Asia Pacific (APAC) regions.

Formerly responsible for leading the company's EMEA region, Jackson will lead over 30 dedicated healthcare offices across three continents. He will also look to expand Sudler & Hennessey's offerings to meet the evolving needs of healthcare clients.

"The APAC region probably has the largest growth potential in healthcare, as well as presenting a number of significant challenges, both geographical, socio-economic, and technological. We are looking forward to continuing our leadership in this region, and to a rich exchange of ideas between the established and developing markets," said Jackson.

Jackson has a strong interest in developing new business models in the digital/new media arena, and in particular, in emerging markets. He has worked in healthcare communications for 19 years, both on the client-side and in various agencies. The last eight years of his career have been spent leading large healthcare communications networks globally and he has extensive global marketing experience.

Jed Beitler, chairman and CEO of Sudler & Hennessey worldwide said: "Max has proven leadership skills, and has demonstrated very quickly that he understands how to navigate through the challenging healthcare marketplace, and help clients find the solutions necessary to maximise their brands potential."

17th February 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics